Published in Hospital and Nursing Home Week, December 28th, 2006
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Savient Pharmaceuticals.
Report 1: Savient Pharmaceuticals, Inc. (SVNT) reported in its financial results for the 3 and 9 months ended September 30, 2006, a Q3 2006 net product sales increase of $4.8 million, up 43% over the prior year's third quarter due to higher sales of Oxandrin of $5.8 million, up 57% for the same period.
Operating profits were $1.6 million for the quarter, compared with an operating loss of $4 million in the third quarter...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital and Nursing Home Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.